Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)-Reference-Cited by-同舟云学术

Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)

Published:2023-05-25 Issue:6 Volume:87 Page:857-865
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Muramatsu Takashi¹,Masuda Shinichiro²,Kotoku Nozomi²,Kozuma Ken³,Kawashima Hideyuki³,Ishibashi Yuki⁴,Nakazawa Gaku⁵,Takahashi Kuniaki⁵,Okamura Takayuki⁶,Miyazaki Yosuke⁶,Tateishi Hiroki⁷,Nakamura Masato⁸,Kogame Norihiro⁹,Asano Taku¹⁰,Nakatani Shimpei¹¹,Morino Yoshihiro¹²,Katagiri Yuki¹³,Ninomiya Kai²,Kageyama Shigetaka²,Takahashi Hiroshi¹⁴,Garg Scot¹⁵,Tu Shengxian¹⁶,Tanabe Kengo¹⁷,Ozaki Yukio¹⁸,Serruys Patrick W.²,Onuma Yoshinobu²

Affiliation:

1. Department of Cardiology, Fujita Health University Hospital

2. Cardiovascular Research Centre for Advanced Imaging and Core Laboratory (CORRIB), University of Galway

3. Teikyo University Hospital

4. Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine

5. Department of Cardiology, Kindai University Faculty of Medicine

6. Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine

7. Department of Cardiology, Shibata Hospital

8. Division of Cardiovascular Medicine, Toho University Ohashi Medical Center

9. Department of Cardiology, Tokyo Rosai Hospital

10. Department of Cardiology, St. Luke’s International Hospital

11. Department of Cardiology, JCHO Hoshigaoka Medical Center

12. Department of Cardiology, Iwate Medical University Hospital

13. Department of Cardiology, Sapporo Higashi Tokushukai Hospital

14. Division of Medical Statistics, Fujita Health University

15. Department of Cardiology, Royal Blackburn Hospital

16. Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University and Shanghai Med-X Engineering Research Center, Shanghai Jiao Tong University

17. Division of Cardiology, Mitsui Memorial Hospital

18. Department of Cardiology, Fujita Health University Okazaki Medical Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/6/87_CJ-23-0051/_pdf

Reference36 articles.

1. 1. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213–260.

2. 2. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 2020; 84: 831–865.

3. 3. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014; 371: 2155–2166.